Poniard Pharmaceuticals: Positive Phase 2 News and Patent Portfolio Could...
Now here is what really caught my attention about PARD, on November 13, 2009 the stock was trading at $7.58, and on Monday, November 16, 2009 it dropped like a rock to $1.83, where it has largely...
View ArticleUS Oncologists Report Crucial Cancer Drug Shortages
The mantra of the anti-patent community is nearly in unison on the issue of patented drugs. Of course, everyone wants drugs to be developed, but no one wants to pay the exorbitant prices charged for...
View ArticlePatent Granted on Long-Acting Drug for Multiple Sclerosis
The conjugates covered by this patent could enable less frequent and better tolerated dosing of one of the most widely used treatments worldwide for relapsing-remitting multiple sclerosis,...
View ArticleFTC Upholds Decision on Deceptive Advertising of Pomegranate Products
The Commission issued a Final Order that bars the POM marketers from making any claim that a food, drug, or dietary supplement is “effective in the diagnosis, cure, mitigation, treatment, or prevention...
View ArticleInnovation at Historically Black Colleges and Universities
The first patent received by an HBCU was on April 11, 1978, assigned to Shaw University of Raleigh, NC. Between 1969 and 2012, HBCUs received 100 utility patents from the U.S. Patent and Trademark...
View ArticleFederal funding for a cancer moonshot is not a terrible idea
To hear Ars Technica say it is ''a terrible idea'' to devote increased funding in order to eradicate cancer is astonishing on many levels. As part of the reason why he believes increased funding for...
View ArticleBolder initiatives needed to take next steps in fight against cancer
February 4 is World Cancer Day... There has been steady progress made in the history of treating cancers of many types since the administration of former U.S President Richard Nixon, according to Dr....
View ArticleBlue Ribbon Panel of Advisors Announced for Biden Cancer Moonshot Initiative
Earlier this week the National Cancer Institute (NCI), which is part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates...
View ArticleNIH Director Collins Stands Up to the March in Mob
The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to own inventions made with...
View Article
More Pages to Explore .....